Christian Eriksen's first post after collapse: 'My pacemaker protected me'
Translated from Greek, summarized and contextualized by DistantNews.
At a glance
- Danish footballer Christian Eriksen posted an update on his health, stating he is recovering well at home with his family.
- He confirmed his implantable cardioverter-defibrillator (ICD) protected him, differentiating the incident from his 2021 collapse.
- Eriksen expressed gratitude to medical staff and his family, prioritizing his recovery and spending time with his children.
Danish footballer Christian Eriksen has shared his first update since his on-field collapse, assuring fans he is recovering well at home with his family. The incident, which occurred during a friendly match, was attributed to his implantable cardioverter-defibrillator (ICD).
I want to inform everyone that I am well and that I am at home with my family. As you can imagine, the shock I received from my implantable cardioverter-defibrillator (ICD) had a significant impact on both me and my family, but I want to assure everyone that this was a different situation from what happened in 2021.
Eriksen clarified that this situation was different from his previous health scare in 2021. He emphasized that his ICD functioned as designed, protecting him when needed. He expressed profound gratitude for the support from his teammates, medical personnel, and the doctors who have managed his heart condition over the years.
I feel well and my recovery has already begun.
Currently, Eriksen's focus is on his recovery. He plans to take a vacation and spend quality time playing football with his children. His statement conveys a sense of relief and a positive outlook on his return to normalcy.
I am incredibly grateful to the doctors who take care of me and my heart all these years. Thanks to their expertise, my ICD did exactly what it was designed to do: protect me when I needed it.
Originally published by Ta Nea in Greek. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.